Related Experiment Video

Updated: Sep 23, 2026

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

Evolution of cholesterol management therapies: exploiting potential for further improvement

Michael Clearfield1

  • 1Department of Internal Medicine, Health Science Center, University of North Texas, Fort Worth, Texas 76107, USA. mclearfi@hsc.unt.edu

American Journal of Therapeutics
|July 8, 2003
PubMed

Insights

Atherosclerosis therapies have evolved significantly, with statins being the most effective cholesterol-lowering drugs. Ongoing research aims to develop new agents with improved efficacy and broader benefits for cardiovascular health.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Drug Discovery

Background:

  • Atherosclerosis therapies have advanced over decades, heavily influenced by population studies.
  • Statins represent the most successful drug class for managing cholesterol and atherosclerosis.
  • Current treatments have limitations, driving the need for novel therapeutic strategies.

Purpose of the Study:

  • To review the evolution of atherosclerosis therapies.
  • To highlight the role of statins in cholesterol management.
  • To discuss the development of new cholesterol-lowering agents.

Main Methods:

  • Literature review of population studies and drug development.
  • Analysis of current therapeutic shortfalls.
  • Examination of emerging cholesterol-control agents and their potential.

Main Results:

  • Population studies over 40 years have informed current therapies.
  • Statins demonstrate significant efficacy in reducing cholesterol.
  • New statins like rosuvastatin and pitavastatin show enhanced efficacy and broader risk factor management.

Conclusions:

  • Therapeutic development for atherosclerosis is a continuous process.
  • Newer statins offer improved cholesterol reduction and additional cardiovascular benefits.
  • Future therapies aim to overcome existing treatment limitations and enhance patient outcomes.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...